1. Home
  2. AVDL vs WRLD Comparison

AVDL vs WRLD Comparison

Compare AVDL & WRLD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • AVDL
  • WRLD
  • Stock Information
  • Founded
  • AVDL 2015
  • WRLD 1962
  • Country
  • AVDL Ireland
  • WRLD United States
  • Employees
  • AVDL N/A
  • WRLD N/A
  • Industry
  • AVDL Biotechnology: Pharmaceutical Preparations
  • WRLD Finance: Consumer Services
  • Sector
  • AVDL Health Care
  • WRLD Finance
  • Exchange
  • AVDL Nasdaq
  • WRLD Nasdaq
  • Market Cap
  • AVDL 861.4M
  • WRLD 825.5M
  • IPO Year
  • AVDL 1996
  • WRLD 1991
  • Fundamental
  • Price
  • AVDL $10.04
  • WRLD $170.85
  • Analyst Decision
  • AVDL Strong Buy
  • WRLD
  • Analyst Count
  • AVDL 6
  • WRLD 0
  • Target Price
  • AVDL $18.17
  • WRLD N/A
  • AVG Volume (30 Days)
  • AVDL 1.6M
  • WRLD 69.9K
  • Earning Date
  • AVDL 08-07-2025
  • WRLD 07-25-2025
  • Dividend Yield
  • AVDL N/A
  • WRLD N/A
  • EPS Growth
  • AVDL N/A
  • WRLD 23.58
  • EPS
  • AVDL N/A
  • WRLD 16.30
  • Revenue
  • AVDL $194,450,000.00
  • WRLD $564,781,378.00
  • Revenue This Year
  • AVDL $56.88
  • WRLD N/A
  • Revenue Next Year
  • AVDL $29.81
  • WRLD N/A
  • P/E Ratio
  • AVDL N/A
  • WRLD $10.50
  • Revenue Growth
  • AVDL 252.64
  • WRLD N/A
  • 52 Week Low
  • AVDL $6.38
  • WRLD $101.85
  • 52 Week High
  • AVDL $17.30
  • WRLD $177.25
  • Technical
  • Relative Strength Index (RSI)
  • AVDL 63.41
  • WRLD 61.03
  • Support Level
  • AVDL $8.74
  • WRLD $170.26
  • Resistance Level
  • AVDL $9.56
  • WRLD $177.25
  • Average True Range (ATR)
  • AVDL 0.40
  • WRLD 4.69
  • MACD
  • AVDL 0.08
  • WRLD -0.18
  • Stochastic Oscillator
  • AVDL 98.70
  • WRLD 68.79

About AVDL Avadel Pharmaceuticals plc

Avadel Pharmaceuticals PLC is a specialty pharmaceutical company. The group focused on transforming medicines to transform lives. It provides solutions to the development of medications that address the challenges patients face with current treatment options. The company is engaged in the development of differentiated drug products for administration in various forms such as capsules, tablets, injectables etc. Its commercialized product LUMRYZ is an extended-release formulation of sodium oxybate indicated to be taken once at bedtime for the treatment of cataplexy or EDS in adults with narcolepsy. It operates in one segment, the development and commercialization of pharmaceutical products, including controlled-release therapeutic products based on its proprietary polymer-based technology.

About WRLD World Acceptance Corporation

World Acceptance Corp operates a small-loan consumer finance business. The company offers short-term small installment loans, medium-term larger installment loans, related credit insurance and ancillary products and services to individuals. It also offers income tax return preparation services to its loan customers and other individuals. The Company operates 1,024 branches in Alabama, Georgia, Idaho, Illinois, Indiana, Kentucky, Louisiana, Mississippi, Missouri, New Mexico, Oklahoma, South Carolina, Texas, Tennessee, Utah, and Wisconsin.

Share on Social Networks: